Articles

FDA authorizes emergency use of Moderna booster in individuals 18 and older

Industrialized collaboration is critical to taking next-generation cell and gene therapies to the next level—if companies can build on pandemic-partnering momentum

The Key Force in CGT Commercialization

PBM fees and vertical integration are also at the top of the list

NCPA survey: Independent pharmacies impacted by supply chain, labor disruptions

Partnership further increases investment firm’s repertoire in healthcare space  

The Vistria Group acquires BioCare

Latest report shows that demand is above pre-crisis numbers, but there are still capacity constraints

IATA unveils September air cargo numbers

Centers for Disease Control and Prevention endorses Pfizer-BioNTech jab, less than two months after firms presented positive study results

CDC signs off on pediatric Covid vaccine for young children ages 5 to 11

Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023

The pace of DSCSA readiness preparations has slowed, says annual HDA survey

Anticipated capacity of GMP facility is 60 million vials per year

WuXi Biologics debuts new commercial drug product plant

A total of 116.5 million doses for low- and middle-income nations to arrive in Q2 of 2022

Moderna to provide an additional 56.5 million vaccine doses to Gavi

Facility features cell storage for CAR-T cell treatments

Supply Chain Logistics